HBIO Harvard Bioscience, Inc.

NAS · US · Healthcare · Medical Instruments & Supplies · harvardbioscience.com

8.500USD-0.70%Mkt Cap: 38.69M $P/E: —1d ago

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offer…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$146.44BUSDP/E 47.5

EssilorLuxottica Société anonyme

$71.30BUSDP/E 26.7

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$25.79BUSDP/E 46.9

DIM

Sartorius Stedim Biotech S.A.

$22.00BUSDP/E 69.1

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.68BUSDP/E 69.1

SOLV

Solventum Corporation

$14.62BUSDP/E 10.5

BAX

Baxter International Inc.

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap38.69M USD

Enterprise Value76.53M USD

Revenue (TTM)87.81M USD

Gross Profit49.91M USD

Net Income (TTM)-56.70M USD

Revenue/Share19.64 USD

Last Price8.500 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees316

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)13.27

PEG1.31

EV/EBITDA10.38

EV/Revenue0.87

P/S0.44

P/B5.25

EPS (TTM)-2.32

EPS (Forward)0.65

52W Range

3.80084% of range9.400

52W High9.400 USD

52W Low3.800 USD

Profitability

Gross Margin57.67%

Oper. Margin-2.90%

EBITDA Margin8.39%

Profit Margin-65.51%

ROE-412.84%

ROA-70.81%

Growth

Revenue Growth11.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF6.73M USD

CapEx (TTM)1.86M USD

FCF Margin6.04%

FCF Yield13.71%

Net Debt37.70M USD

Net Debt/EBITDA5.12

Balance Sheet

Debt/Equity3.22

Current Ratio1.87

Quick Ratio0.85

Book Value/Sh1.63 USD

Cash/Share1.43 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateMar 16, 2026

Analyst Consensus

Rating—

Target (Mean)7.500 USD

Upside (mean)-11.8%

Target Range7.500 USD – 7.500 USD

# Analysts1

Ownership

Shares Out.4.55M

Float3.66M

Insiders9.40%

Institutions42.01%

Short Interest

Short Ratio2.3d

Short % Float1.08%

Short % Out.1.06%

Shares Short48.15K

Short (prev mo.)58.83K

Technical

SMA 507.438 (+14.3%)

SMA 2006.294 (+35.1%)

Beta1.51

S&P 52W Chg16.45%

Avg Vol (30d)17.61K

Avg Vol (10d)21.23K

Technical Indicators

RSI (14)71.3

MACD0.2985

MACD Signal0.2959

MACD Hist.+0.0026

BB Upper8.512 USD

BB Middle8.097 USD

BB Lower7.681 USD

BB Width10.26%

ATR (14)0.2460 USD

Vol Ratio (20d)0.46x